Psoriasis: assessment and management

National Institute for Health and Care Excellence

In the UK, it is estimated that around 1.3–2.2% will have psoriasis. This skin condition can occur at any age, although is uncommon in children (0.71%) and the majority of cases occur before 35 years.

Psoriasis for many people results in profound functional, psychological, and social morbidity, with consequent reduced levels of employment and income. Factors that contribute to this include symptoms related to the skin (for example, chronic itch, bleeding, scaling, and nail involvement), problems related to treatments, psoriatic arthritis, and the effects of living with a highly visible, stigmatising skin disease. Even people with minimal involvement state that psoriasis has a major impact on their life. Several studies have also reported that people with psoriasis, particularly those with severe disease, may be at increased risk of cardiovascular disease, lymphoma, and non-melanoma skin cancer.

This Guidelines summary covers assessment, referral, topical therapies, and systemic therapy recommendations that are relevant to primary care.

Register to view this page

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Log in

Need help? Email us